GBS

GBS Inc. Reports First Quarter 2021 Financial Results and Recent Business Highlights

GBS, Inc. Receives Approval to Commence Validation Clinical Study for Rapid SARS-CoV-2 Diagnostic Test

GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests

GBS, Inc. Announces Closing of Upsized $21.6 Million Initial Public Offering

UPDATE - GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering